Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 32 studies | 41% ± 15% | |
astrocyte | 18 studies | 35% ± 17% | |
oligodendrocyte precursor cell | 14 studies | 46% ± 19% | |
microglial cell | 11 studies | 33% ± 13% | |
capillary endothelial cell | 10 studies | 31% ± 14% | |
macrophage | 10 studies | 28% ± 11% | |
adipocyte | 8 studies | 23% ± 3% | |
dendritic cell | 8 studies | 33% ± 8% | |
endothelial cell of artery | 8 studies | 31% ± 12% | |
vein endothelial cell | 8 studies | 30% ± 19% | |
endothelial cell of lymphatic vessel | 8 studies | 41% ± 12% | |
myeloid cell | 6 studies | 28% ± 9% | |
cardiac muscle cell | 5 studies | 32% ± 9% | |
type I pneumocyte | 5 studies | 36% ± 9% | |
type II pneumocyte | 5 studies | 35% ± 11% | |
endothelial cell of vascular tree | 4 studies | 53% ± 17% | |
monocyte | 4 studies | 33% ± 14% | |
pericyte | 3 studies | 21% ± 4% | |
alveolar macrophage | 3 studies | 38% ± 5% | |
fibroblast | 3 studies | 22% ± 4% | |
plasmacytoid dendritic cell | 3 studies | 19% ± 3% | |
mast cell | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 2585.48 | 1808 / 1809 | 98% | 31.27 | 464 / 472 |
thymus | 100% | 4845.73 | 653 / 653 | 98% | 24.51 | 592 / 605 |
brain | 96% | 1527.90 | 2539 / 2642 | 100% | 48.77 | 705 / 705 |
breast | 100% | 4393.13 | 459 / 459 | 95% | 14.40 | 1060 / 1118 |
kidney | 99% | 1489.55 | 88 / 89 | 90% | 18.60 | 808 / 901 |
lung | 100% | 5988.35 | 578 / 578 | 85% | 11.49 | 978 / 1155 |
esophagus | 97% | 1994.26 | 1395 / 1445 | 82% | 8.95 | 150 / 183 |
intestine | 100% | 2350.37 | 962 / 966 | 66% | 6.19 | 348 / 527 |
stomach | 84% | 1223.49 | 302 / 359 | 77% | 8.88 | 219 / 286 |
bladder | 100% | 1941.43 | 21 / 21 | 58% | 5.40 | 294 / 504 |
prostate | 98% | 1535.96 | 241 / 245 | 58% | 4.29 | 293 / 502 |
uterus | 100% | 2761.69 | 170 / 170 | 52% | 5.00 | 238 / 459 |
ovary | 100% | 1796.86 | 180 / 180 | 47% | 3.68 | 201 / 430 |
pancreas | 41% | 332.48 | 136 / 328 | 90% | 10.77 | 160 / 178 |
adrenal gland | 85% | 842.14 | 219 / 258 | 45% | 3.91 | 104 / 230 |
adipose | 100% | 5250.83 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 1929.27 | 241 / 241 | 0% | 0 | 0 / 0 |
heart | 100% | 3399.77 | 859 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 1917.92 | 1310 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 14.33 | 25 / 29 |
tonsil | 0% | 0 | 0 / 0 | 71% | 9.84 | 32 / 45 |
eye | 0% | 0 | 0 / 0 | 65% | 4.97 | 52 / 80 |
muscle | 56% | 471.83 | 452 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 35% | 1082.25 | 325 / 929 | 0% | 0 | 0 / 0 |
liver | 10% | 77.55 | 22 / 226 | 22% | 1.60 | 90 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051056 | Biological process | regulation of small GTPase mediated signal transduction |
GO_0007264 | Biological process | small GTPase-mediated signal transduction |
GO_0005829 | Cellular component | cytosol |
GO_0030027 | Cellular component | lamellipodium |
GO_0005925 | Cellular component | focal adhesion |
GO_0005515 | Molecular function | protein binding |
GO_0005096 | Molecular function | GTPase activator activity |
GO_0017124 | Molecular function | SH3 domain binding |
Gene name | ARHGAP31 |
Protein name | Rho GTPase-activating protein 31 (Cdc42 GTPase-activating protein) Cdc42 GTPase-activating protein, isoform CRA_a (Rho GTPase activating protein 31) ARHGAP31 Rho GTPase activating protein 31 |
Synonyms | hCG_22571 CDGAP KIAA1204 |
Description | FUNCTION: Functions as a GTPase-activating protein (GAP) for RAC1 and CDC42. Required for cell spreading, polarized lamellipodia formation and cell migration. . |
Accessions | A0A2X0SF93 ENST00000264245.9 ENST00000482743.1 Q2M1Z3 A0A8S0M5T0 C9J652 A0A8S0MHV1 |